Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

DB Costa, KSH Nguyen, BC Cho, LV Sequist… - Clinical cancer …, 2008 - AACR
Purpose: Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib; however, resistance to this tyrosine kinase inhibitor (TKI) …
被引用次数：216 相关文章

Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib

DB Costa, KSH Nguyen, BC Cho… - Clinical Cancer …, 2008 - einstein.elsevierpure.com
Purpose: Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib; however, resistance to this tyrosine kinase inhibitor (TKI) …

Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib

DB Costa, KSH Nguyen, BC Cho… - Clinical Cancer …, 2008 - yonsei.elsevierpure.com
Purpose: Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib; however, resistance to this tyrosine kinase inhibitor (TKI) …

Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib

DB Costa, KSH Nguyen, BC Cho… - … : an official journal …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib; however, resistance to this tyrosine kinase inhibitor (TKI) …

Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.

DB Costa, KS Nguyen, BC Cho, LV Sequist… - … Cancer Research: an …, 2008 - europepmc.org
Purpose Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib; however, resistance to this tyrosine kinase inhibitor (TKI) …

[引用][C] Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

DB COSTA, KSH NGUYEN… - Clinical cancer …, 2008 - pascal-francis.inist.fr
Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to
Gefitinib CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[HTML] nih.gov

[HTML][HTML] Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib

DB Costa, KSH Nguyen, BC Cho… - … cancer research: an …, 2008 - ncbi.nlm.nih.gov
Purpose: Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib, however resistance to this tyrosine kinase inhibitor (TKI) …
[PDF] researchgate.net

[PDF][PDF] Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib

DB Costa, KSH Nguyen, BC Cho, LV Sequist… - Clin Cancer …, 2008 - researchgate.net
Purpose: Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib, however resistance to this tyrosine kinase inhibitor (TKI) …

Effects of Erlotinib in EGFR Mutated Non-Small Cell Lung Cancers with Resistance to Gefitinib

DB Costa, KSH Nguyen, BC Cho, LV Sequist… - Clinical Cancer …, 2008 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: Most lung cancers with activating
epidermal growth factor receptor (EGFR) mutations respond to gefitinib; however, resistance …

Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.

DB Costa, KS Nguyen, BC Cho, LV Sequist… - … Cancer Research: an …, 2008 - europepmc.org
Purpose Most lung cancers with activating epidermal growth factor receptor (EGFR)
mutations respond to gefitinib; however, resistance to this tyrosine kinase inhibitor (TKI) …